Pfizer’s RSV vaccine trials reportedly showing promise, FDA plans second round of Omicron boosters

Yahoo Finance health reporter Anjalee Khemlani highlights the latest developments surrounding Pfizer's respiratory syncytial virus vaccine and the FDA's plans for another round of Omicron booster shorts for vulnerable Americans.